Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for OptimizeRx Corp. (OPRX : NSDQ)

• Company Description    OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan. Number of Employees: 105

• Price / Volume Information    Yesterday's Closing Price: $6.62 Daily Weekly Monthly 20 Day Moving Average: 526,917 shares Shares Outstanding: 18.76 (millions) Market Capitalization: $124.21 (millions) Beta: 1.20 52 Week High: $22.25 52 Week Low: $5.54 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.15% -18.63% 12 Week -48.04% -46.54% Year To Date -46.00% -44.96%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 260 CHARLES STREET SUITE 302 - WALTHAM,MA 02453 USA ph: 248-651-6568 fax: 248-453-5529 shalper@lifesciadvisors.com http://www.optimizerx.com

• General Corporate Information    Officers Stephen Silvestro - Chief Executive Officer Lynn O`Connor Vos - Chairperson Edward Stelmakh - Chief Financial Officer Patrick Spangler - Director James Lang - Director Peer Information OptimizeRx Corp. (ATEA) OptimizeRx Corp. (BITS.) OptimizeRx Corp. (DCTM) OptimizeRx Corp. (DLVAZ) OptimizeRx Corp. (DOCC) OptimizeRx Corp. (NEON) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: COMP-SOFTWARE Sector: Computer and Technology CUSIP: 68401U204 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/11/26 Share - Related Items Shares Outstanding: 18.76 Most Recent Split Date: 5.00 (0.33:1) Beta: 1.20 Market Capitalization: $124.21 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.55 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/11/26

• Fundamental Ratios P/E Current FY Estimate: 12.04 Trailing 12 Months: 9.88 PEG Ratio: - Price Ratios Price/Book: 0.96 Price/Cash Flow: 6.73 Price / Sales: 1.14 EPS Growth vs. Year Ago Period: 192.86% vs. Previous Quarter: 310.00% Sales Growth vs. Year Ago Period: -0.24% vs. Previous Quarter: 23.68% ROE 12/31/25 - 10.61 09/30/25 - 6.37 06/30/25 - 4.50 ROA 12/31/25 - 7.54 09/30/25 - 4.46 06/30/25 - 3.12 Current Ratio 12/31/25 - 3.04 09/30/25 - 3.05 06/30/25 - 2.57 Quick Ratio 12/31/25 - 3.04 09/30/25 - 3.05 06/30/25 - 2.57 Operating Margin 12/31/25 - 11.79 09/30/25 - 6.90 06/30/25 - 5.02 Net Margin 12/31/25 - 4.69 09/30/25 - 0.03 06/30/25 - -9.42 Pre-Tax Margin 12/31/25 - 6.35 09/30/25 - 1.54 06/30/25 - -8.88 Book Value 12/31/25 - 6.88 09/30/25 - 6.56 06/30/25 - 6.43 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - 0.17 09/30/25 - 0.20 06/30/25 - 0.21 Debt-to-Capital 12/31/25 - 14.31 09/30/25 - 16.86 06/30/25 - 17.40

Powered by Zacks Investment Research ©